One To Watch

KSQ Therapeutics

A clinical-stage biotechnology company developing cancer therapies using its proprietary CRISPRomics discovery platform.

The USA-based company's CRISPRomics discovery engine enables genome-scale, in vivo validated, unbiased drug discovery across broad therapeutic areas. In particular, KSQ is advancing a pipeline of tumor- and immune-focused drug candidates to treat cancer.

Want to Update your Company's Profile?